Sean Nicholson, professor of public policy, says Amazon is introducing the generics program to boost their subscriptions, compel people to switch to Amazon for higher-margin branded drugs, and entice them to spend more on other products, but he notes “it’s not going to do much, if anything, to push down spending on drugs that don’t face generic competition.”